A world level of bio new drug R&D center in Daedeok Research Cluster.

Published: 2007-04-11 06:59:00

Updated: 2007-04-11 06:59:00

The Korea Institute of Toxicology (KIT) and an American bio pharmaceutical company, ISIS, planned to establish "KIT-ISIS Bio New Drug R&D Center" in attendance of Daedeok Innopolice for a successful development of bio new drugs including an anti-sense, protein new drugs and cellular therapies in ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK